Literature DB >> 19737910

Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.

Rebecca J Gorrell1, Roy M Robins-Browne.   

Abstract

Studies of active immunization against Helicobacter pylori indicate that antibodies play a minor role in immunity. There is also evidence, however, that the translocation of antibodies in the stomach may be insufficient to achieve functional antibody levels in the gastric lumen. We have used a suckling mouse model of passive immunity to determine if perorally delivered antibodies can protect against infection with H. pylori. Female C57BL/6 mice were immunized parenterally with formalin-fixed cells of three clinical isolates of H. pylori (3HP) or the mouse-adapted H. pylori strain SS1 before mating. Their pups were challenged with the SS1 strain at 4 days of age and left to suckle before determination of bacterial loads 14 days later. Compared to age-matched controls, pups suckled by 3HP-vaccinated dams were significantly protected against infection (>95% reduction in median bacterial load; P<0.0001). Pups suckled by SS1-vaccinated dams were also significantly protected in terms of both median bacterial load (>99.5% reduction; P<0.0001) and the number of culture-negative pups (28% versus 2% for immune and nonimmune cohorts, respectively; P<0.0001). Similar results were obtained with pups suckled by dams immunized with a urease-deficient mutant of SS1. Fostering experiments demonstrated that protection was entirely attributable to suckling from an immunized dam, and antibody isotype analysis suggested that protection was mediated by the immunoglobulin G fraction of immune milk. Analysis of the bacterial loads in pups sampled before and after weaning confirmed that infection had been prevented in culture-negative animals. These data indicate that antibodies can prevent colonization by H. pylori and suppress the bacterial loads in animals that are colonized.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19737910      PMCID: PMC2772510          DOI: 10.1128/IAI.00547-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  61 in total

Review 1.  Changes in gastric mucosa and luminal environment during acid-suppressive therapy: a review in depth.

Authors:  S Sanduleanu; D Jonkers; A de Bruïne; W Hameeteman; R W Stockbrügger
Journal:  Dig Liver Dis       Date:  2001-11       Impact factor: 4.088

Review 2.  The design of vaccines against Helicobacter pylori and their development.

Authors:  G Del Giudice; A Covacci; J L Telford; C Montecucco; R Rappuoli
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

3.  Lymphocyte homing and Ig secretion in the murine mammary gland.

Authors:  M J van der Feltz; N de Groot; J P Bayley; S H Lee; M P Verbeet; H A de Boer
Journal:  Scand J Immunol       Date:  2001-09       Impact factor: 3.487

4.  Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones.

Authors:  V Sanchez; S Gimenez; J Haensler; C Geoffroy; B Rokbi; D Seguin; L Lissolo; B Harris; F Rizvi; H Kleanthous; T Monath; M Cadoz; B Guy
Journal:  FEMS Immunol Med Microbiol       Date:  2001-03

5.  Differential recruitment of T- and IgA B-lymphocytes in the developing mammary gland in relation to homing receptors and vascular addressins.

Authors:  G M Tanneau; L Hibrand-Saint Oyant; C C Chevaleyre; H P Salmon
Journal:  J Histochem Cytochem       Date:  1999-12       Impact factor: 2.479

6.  Helicobacter pylori-specific immunoglobulin synthesis in gnotobiotic piglets: evidence for the induction of mucosal immunity in the stomach.

Authors:  Steven Krakowka; K A Eaton
Journal:  Vet Immunol Immunopathol       Date:  2002-09-25       Impact factor: 2.046

7.  Rapid genetic analysis of Helicobacter pylori gastric mucosal colonization in suckling mice.

Authors:  Betty P Guo; John J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

8.  Clearance of Helicobacter pylori Infection and Resolution of Postimmunization Gastritis in a Kinetic Study of Prophylactically Immunized Mice.

Authors:  Christine A Garhart; Raymond W Redline; John G Nedrud; Steven J Czinn
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera.

Authors:  Stefan Schild; Eric J Nelson; Anne L Bishop; Andrew Camilli
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

10.  The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.

Authors:  B Satin; G Del Giudice; V Della Bianca; S Dusi; C Laudanna; F Tonello; D Kelleher; R Rappuoli; C Montecucco; F Rossi
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

View more
  5 in total

1.  Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model.

Authors:  Rodolfo E Bégué; Halina Sadowska-Krowicka
Journal:  FEMS Immunol Med Microbiol       Date:  2010-08-23

2.  Immunological response to parenteral vaccination with recombinant hepatitis B virus surface antigen virus-like particles expressing Helicobacter pylori KatA epitopes in a murine H. pylori challenge model.

Authors:  Michael Kotiw; Megan Johnson; Manisha Pandey; Scott Fry; Stuart L Hazell; Hans J Netter; Michael F Good; Colleen Olive
Journal:  Clin Vaccine Immunol       Date:  2011-12-28

3.  Contribution of secretory antibodies to intestinal mucosal immunity against Helicobacter pylori.

Authors:  Rebecca J Gorrell; Odilia L C Wijburg; John S Pedersen; Anna K Walduck; Terry Kwok; Richard A Strugnell; Roy M Robins-Browne
Journal:  Infect Immun       Date:  2013-08-05       Impact factor: 3.441

4.  The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial.

Authors:  Dailun Hu; Feng Zhang; Jikun Zhou; Baohong Xu; Hongying Zhang; Huiqin Qiang; Shuguang Ren; Baoen Shan; Changfu Yin; Zhitao Zhang; Xian Wang; Chuan Zhao; Zhongli Shi
Journal:  J Transl Med       Date:  2015-06-30       Impact factor: 5.531

5.  Construction, Cloning, and Expression of CagA Recombinant Protein of Helicobacter pylori.

Authors:  Abbas Shapouri Moghaddam; Shamseddin Mansouri; Alireza Neshani; Farzaneh Firoozeh; Azade Matinpur; Azad Khaledi; Mehran Ghazalibina
Journal:  Avicenna J Med Biotechnol       Date:  2020 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.